Alpha Seven Group JSC (HNX:DL1)

Ligand Pharmaceuticals Ratios and Metrics

Market cap in millions VND. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 5, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	754,276	541,804	446,192	318,708	1,477,189	3,085,909
Market Cap Growth	47.83%	21.43%	40.00%	-78.42%	-52.13%	2.35%
Enterprise Value	1,470,583	1,235,806	1,797,076	2,018,914	1,623,817	3,216,553
Last Close Price	7100.00	5100.00	4200.00	3000.00	13904.76	29047.62
PE Ratio	9816.33	390.78	10.58	7.04	32.64	87.17
PS Ratio	1.21	1.03	1.59	1.14	14.67	16.36
PB Ratio	0.54	0.40	0.32	0.24	1.28	2.78
P/TBV Ratio	0.72	0.54	0.38	0.29	1.28	2.79
P/FCF Ratio	-	-	-	1.93	-	186.98
P/OCF Ratio	-	-	-	1.91	-	107.90
EV/Sales Ratio	2.36	2.35	6.39	7.23	16.13	17.05
EV/EBITDA Ratio	7.32	6.74	10.80	12.90	218.99	426.46
EV/EBIT Ratio	13.16	11.38	16.73	20.78	493.78	558.38
EV/FCF Ratio	-2.33	-	-	12.21	-	194.90
Debt / Equity Ratio	0.60	0.64	0.64	1.15	0.70	0.12
Debt / EBITDA Ratio	4.77	4.79	5.36	9.71	107.89	17.32
Debt / FCF Ratio	-	-	-	9.19	-	7.92
Asset Turnover	0.25	0.21	0.11	0.11	0.06	0.14
Inventory Turnover	6.40	6.62	7.04	6.31	6.81	164.26
Quick Ratio	1.27	1.88	1.63	0.65	0.45	0.33
Current Ratio	2.22	2.10	2.01	1.20	1.45	1.12
Return on Equity (ROE)	1.89%	1.91%	5.18%	5.40%	4.02%	3.25%
Return on Assets (ROA)	2.13%	2.72%	2.50%	2.46%	0.12%	0.27%
Return on Capital (ROIC)	2.40%	2.99%	2.61%	2.53%	0.13%	0.29%
Return on Capital Employed (ROCE)	4.30%	5.40%	5.10%	4.20%	0.20%	0.50%
Earnings Yield	0.01%	0.26%	9.46%	14.21%	3.06%	1.15%
FCF Yield	-83.60%	-52.19%	-11.00%	51.87%	-34.13%	0.53%
Buyback Yield / Dilution	-0.43%	-0.36%	-0.03%	-	0.00%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.